Mycophenolate mofetil Active Not Recruiting Phase 2 Trials for Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Recurrent Plasma Cell Myeloma / Refractory Mantle Cell Lymphoma / Recurrent Mantle Cell Lymphoma / Recurrent Small Lymphocytic Lymphoma / Refractory Small Lymphocytic Lymphoma / Myelodysplastic Syndrome / T-Cell Non-Hodgkin Lymphoma / Aggressive Non-Hodgkin Lymphoma / chronic, recurrent Lymphocytic Leukemia / Leukemia Acute Myeloid Leukemia (AML) / Refractory Follicular Lymphoma / Refractory Hodgkin Lymphoma / Recurrent Follicular Lymphoma / Refractory Lymphoplasmacytic Lymphoma / Mixed Phenotype Acute Leukemia (MPAL) / Acute Lymphoblastic Leukaemias (ALL) / Recurrent Lymphoplasmacytic Lymphoma / Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Recurrent Marginal Zone Lymphoma / Chronic Lymphocytic Leukemia (CLL) - Refractory / Myeloproliferative Neoplasms / Acute Biphenotypic Leukemia (ABL) / Recurrent T-Cell Non-Hodgkin Lymphoma / Indolent Non-Hodgkin's Lymphomas / Malignant Lymphomas / Malignant Lymphoma, Large Cell Type Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00723099Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
NCT01252667Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant
NCT00574496Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma